Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1996 Apr;5(2):100–103. doi: 10.1155/S0962935196000166

Inhibition of the production of mediators of inflammation by corticosteroids is a glucocorticoid receptor-mediated process

G S Madretsma 1,2,✉, A P M van Dijk 1,2, C J A M Tak 1, J H P Wilson 2, F J Zijlstra 1
PMCID: PMC2365783  PMID: 18475705

Abstract

In order to find an explanation for corticosteroid resistance we assessed whether inhibition by dexamethasone (DEX) of the stimulated production of TNF-∝, IL-6, PGE2 and LTB4 by peripheral blood mononuclear cells (MNC) depends on binding to the glucocorticoid receptor (GR), and whether it is determined by the number or the affinity of the GR of these cells. GR number and affinity of MNC were determined by means of a whole cell DEX binding assay. MNC were incubated with DEX and LPS or A23187 in the absence or presence of RU486, a potent steroid antagonist. DEX caused a concentration dependent inhibition of TNF-∝, IL-6 and PGE2 production but had no effect on LTB4 production. RU486 significantly blocked the effect of DEX, but no correlations were found between the inhibition of mediator release and the Kd or receptor number.

Full Text

The Full Text of this article is available as a PDF (371.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Byron M. A., Mowat A. G. Corticosteroid prescribing in rheumatoid arthritis--the fiction and the fact. Br J Rheumatol. 1985 May;24(2):164–166. doi: 10.1093/rheumatology/24.2.164. [DOI] [PubMed] [Google Scholar]
  2. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  3. Dunlap N. E., Fulmer J. D. Corticosteroid therapy in asthma. Clin Chest Med. 1984 Dec;5(4):669–683. [PubMed] [Google Scholar]
  4. Guyre P. M., Girard M. T., Morganelli P. M., Manganiello P. D. Glucocorticoid effects on the production and actions of immune cytokines. J Steroid Biochem. 1988;30(1-6):89–93. doi: 10.1016/0022-4731(88)90080-5. [DOI] [PubMed] [Google Scholar]
  5. Kerrebijn K. F., van Essen-Zandvliet E. E., Neijens H. J. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987 Apr;79(4):653–659. doi: 10.1016/s0091-6749(87)80163-x. [DOI] [PubMed] [Google Scholar]
  6. Lamberts S. W., Koper J. W., Biemond P., den Holder F. H., de Jong F. H. Cortisol receptor resistance: the variability of its clinical presentation and response to treatment. J Clin Endocrinol Metab. 1992 Feb;74(2):313–321. doi: 10.1210/jcem.74.2.1309833. [DOI] [PubMed] [Google Scholar]
  7. Lennard-Jones J. E. Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease. Gut. 1983 Mar;24(3):177–181. doi: 10.1136/gut.24.3.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lewis R. A., Austen K. F. The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. J Clin Invest. 1984 Apr;73(4):889–897. doi: 10.1172/JCI111312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lichtiger S., Present D. H., Kornbluth A., Gelernt I., Bauer J., Galler G., Michelassi F., Hanauer S. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994 Jun 30;330(26):1841–1845. doi: 10.1056/NEJM199406303302601. [DOI] [PubMed] [Google Scholar]
  10. Munkholm P., Langholz E., Davidsen M., Binder V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut. 1994 Mar;35(3):360–362. doi: 10.1136/gut.35.3.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. O'Banion M. K., Winn V. D., Young D. A. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4888–4892. doi: 10.1073/pnas.89.11.4888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pruimboom W. M., van Dijk J. A., Tak C. J., Garrelds I., Bonta I. L., Wilson P. J., Zijlstra F. J. Interactions between cytokines and eicosanoids: a study using human peritoneal macrophages. Immunol Lett. 1994 Jul;41(2-3):255–260. doi: 10.1016/0165-2478(94)90142-2. [DOI] [PubMed] [Google Scholar]
  13. Schumert R., Towner J., Zipser R. D. Role of eicosanoids in human and experimental colitis. Dig Dis Sci. 1988 Mar;33(3 Suppl):58S–64S. doi: 10.1007/BF01538132. [DOI] [PubMed] [Google Scholar]
  14. Shipman G. F., Bloomfield C. D., Gajl-Peczalska K. J., Munck A. U., Smith K. A. Glucocorticoids and lymphocytes. III. Effects of glucocorticoid administration on lymphocyte glucocorticoid receptors. Blood. 1983 Jun;61(6):1086–1090. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES